$WELL

WELLTOWER INC.

Insider trades
1
0
1

No SEC Form 4 filings for $WELL in the last 30 days.

See all $WELL insider activity →
Low

US CEO pay surges, Goldman Sachs and Welltower under spotlight

Reuters reports S&P 500 CEO pay (excluding Elon Musk) averaged $22.8m in 2025, up 21% from 2024. Goldman Sachs paid CEO David Solomon $118.9m, with 71% shareholder support for the pay vote. Welltower awarded CEO Shankh Mitra $821m, with 19% support. CEO-to-worker pay rose to 312x.

Welltower Stock: Analyst Estimates & Ratings

Welltower Inc. (WELL) is a healthcare REIT. The article cites WELL’s stock performance versus the S&P 500 and REZ, and attributes gains to senior housing NOI growth, occupancy recovery, pricing power, demographics, and capital recycling. It reports Q2 FFO of $1.60 vs $1.55 expected, revenue $3.5B, and full-year FFO guidance $3.11 to $3.19. Analysts rate it a “Strong Buy” with a KeyBanc $275 target.

Welltower Notches $6.2B in Acquisitions During 2Q, Mostly Off

Welltower (NYSE: WELL) reported 30 Q2 transactions totaling $6.2B, mainly off-market, and said it has completed or is under contract for $15.5B of deals this year. The company attributed faster deal timelines and cash-flow improvements to its Welltower Business System. It also reported 2Q26 same-store SHO revenue +9.2% and occupancy 87.6%.

WELL sentiment & insider activity

Over the past 7 days, alphai's AI scored 2 news stories mentioning WELL (WELLTOWER INC.). Coverage has been balanced: 1 bullish, 0 neutral, and 1 bearish.

Recent WELL coverage spans earnings, financial news and market movers.

What's driving WELL

  • Extremely low say-on-pay support signals heightened investor backlash and potential board/compensation committee scrutiny.

    idnfinancials.com · Aug 14, 2026

  • The article provides fresh earnings datapoints and forward FFO guidance, supporting a near-term valuation and estimate-revision trade.

    yahoo.com · Aug 12, 2026

  • The article frames WELL’s growth as execution-driven, with faster deal cycles and a business-system rollout aimed at improving cash flow and NOI.

    seniorhousingnews.com · Jul 29, 2026

  • The earnings datapoints plus disclosed acquisition/disposition pipeline strengthen near-term cash-flow and growth expectations for WELL.

    commercialobserver.com · Jul 28, 2026

  • The article attributes today’s pullback to a normalized FFO miss versus elevated expectations, plus profit-taking and a risk-off tape.

    investing.com · Jul 28, 2026

alphai scores every news story that mentions WELL with an AI model for sentiment and relevance, and aggregates insider trades from WELLTOWER INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $WELL

Score
$WELLMed

Welltower Stock: Analyst Estimates & Ratings

Welltower Inc. (WELL) is a healthcare REIT. The article cites WELL’s stock performance versus the S&P 500 and REZ, and attributes gains to senior housing NOI growth, occupancy recovery, pricing power, demographics, and capital recycling. It reports Q2 FFO of $1.60 vs $1.55 expected, revenue $3.5B, and full-year FFO guidance $3.11 to $3.19. Analysts rate it a “Strong Buy” with a KeyBanc $275 target.

Welltower Notches $6.2B in Acquisitions During 2Q, Mostly Off

Welltower (NYSE: WELL) reported 30 Q2 transactions totaling $6.2B, mainly off-market, and said it has completed or is under contract for $15.5B of deals this year. The company attributed faster deal timelines and cash-flow improvements to its Welltower Business System. It also reported 2Q26 same-store SHO revenue +9.2% and occupancy 87.6%.

Welltower Reports Revenue and Income Growth From Senior Housing Investments – Commercial Observer

Welltower reported Q2 2026 results and balance sheet progress. On an earnings call, the REIT cited acquisitions including Amica Senior Lifestyles (38 communities, $1.91B) and a July 2 Canada deal (five development properties, ~$459M). It also disposed of $7.2B outpatient medical properties. Q2 revenue rose to $3.54B, FFO to $1.60/share, and net income to $12.2B.

$WELLMed

Why is Welltower stock sliding today? By Investing.com

Welltower shares fell about 1.6% in morning trading after a gap up tied to its Q2 2026 results. Revenue rose to $3.54B, above consensus of ~$3.36B, but normalized FFO was $1.60 per diluted share, below ~$1.66. UBS reiterated Buy and a $271 target, and Welltower raised 2026 normalized FFO guidance and its quarterly dividend to $0.85 (+14.9%).

$KOMed

Stocks making the biggest moves premarket: Coca-Cola, Sherwin-Williams, Johnson & Johnson & more

Premarket movers included Coca-Cola, Sherwin-Williams, Hilton, Johnson & Johnson, Corning, Cadence Design Systems, Rambus, Universal Health Services, Welltower, Happen (formerly LendingClub), and Cincinnati Financial. Key catalysts were earnings beats or misses and guidance changes, including J&J’s $5.5 billion talc settlement and Coca-Cola’s raised outlook after EPS and revenue topped estimates.

$CDNSMed

Stocks making the biggest moves after hours: Cadence Design Systems, Rambus, Welltower and more

After-hours movers included Cadence Design Systems, up over 4% after Q2 adjusted EPS of $2.11 vs $2.05 expected, with revenue $1.58B in line. Rambus rose after Q2 adjusted EPS of 77 cents vs 72 cents expected, revenue $207M vs $198M. UHS fell over 4% after lowering full-year guidance; Welltower rose 4% after raising normalized FFO guidance to $6.36-$6.44 vs $6.30 expected. Other moves: Happen, F5, Cincinnati Financial, Nucor, Principal Financial Group.

$WELLMed

Welltower Raised Its 2026 Outlook Again As Senior Housing Fills Up

Welltower raised its 2026 outlook again, citing improving senior housing occupancy, pricing, and operating efficiency. The company increased its quarterly dividend 15% to $0.85. It said the dividend is covered by 2026 FFO of $6.36 to $6.44, implying an annualized payout of about $3.40 per share and a low-to-mid 50% payout ratio.

Related tickers